SPECTROFAP
Diagnostic radiopharmaceutical preparations for in vivo use in detecting fibrosis, arthritis, atherosclerosis, autoimmune diseases, metabolic diseases, pulmonary fibrosis, renal fibrosis, and cancer and for in vivo use in detecting expression of fibroblast activation protein, using image detection; radioactive substances for medical purposes for in vivo use in the detection of fibrosis, arthritis, atherosclerosis, autoimmune diseases, metabolic diseases, pulmonary fibrosis, renal fibrosis, an...
Pending · August 9, 2024 · 79405082 ·